Glioblastoma initiating cells are sensitive to histone demethylase inhibition due to epigenetic deregulation

0Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

Abstract

Tumor-initiating cells are a subpopulation of cells that have self-renewal capacity to regenerate a tumor. Here, we identify stem cell-like chromatin features in human glioblastoma initiating cells (GICs) and link them to a loss of the repressive histone H3 lysine 9 trimethylation (H3K9me3) mark. Increasing H3K9me3 levels by histone demethylase inhibition led to cell death in GICs but not in their differentiated counterparts. The induction of apoptosis was accompanied by a loss of the activating H3 lysine 9 acetylation (H3K9ac) modification and accumulation of DNA damage and downregulation of DNA damage response genes. Upon knockdown of histone demethylases, KDM4C and KDM7A both differentiation and DNA damage were induced. Thus, the H3K9me3–H3K9ac equilibrium is crucial for GIC viability and represents a chromatin feature that can be exploited to specifically target this tumor subpopulation.

Cite

CITATION STYLE

APA

Mallm, J. P., Windisch, P., Biran, A., Gal, Z., Schumacher, S., Glass, R., … Rippe, K. (2020). Glioblastoma initiating cells are sensitive to histone demethylase inhibition due to epigenetic deregulation. International Journal of Cancer, 146(5), 1281–1292. https://doi.org/10.1002/ijc.32649

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free